BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37005100)

  • 1. Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension.
    Stolfo D; Barbisan D; Ameri P; Lombardi CM; Monti S; Driussi M; Zovatto IC; Gentile P; Howard L; Toma M; Pagnesi M; Collini V; Bauleo C; Guglielmi G; Adamo M; D'Angelo L; Nalli C; Sciarrone P; Moschella M; Zorzi B; Vecchiato V; Milani M; Di Poi E; Airò E; Metra M; Garascia A; Sinagra G; Lo Giudice F
    J Heart Lung Transplant; 2023 Aug; 42(8):1082-1092. PubMed ID: 37005100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Risk Stratification Scores in Pulmonary Arterial Hypertension: A Monocentric Retrospective Study at Lausanne University Hospital.
    Vraka A; Yerly P; Aubert JD
    Respiration; 2022; 101(6):565-576. PubMed ID: 35045412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The added value of right ventricular function normalized for afterload to improve risk stratification of patients with pulmonary arterial hypertension.
    Vicenzi M; Caravita S; Rota I; Casella R; Deboeck G; Beretta L; Lombi A; Vachiery JL
    PLoS One; 2022; 17(5):e0265059. PubMed ID: 35587927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of risk assessment tools in predicting hemodynamic outcome after balloon pulmonary angioplasty: a comparative analysis.
    Li X; Zhang Y; Zhao Q; Yang T; Zeng Q; Jin Q; Duan A; Huang Z; Hu M; Zhang S; Gao L; Xiong C; Luo Q; Zhao Z; Liu Z
    Postgrad Med; 2024 May; 136(4):446-455. PubMed ID: 38785198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the European Society of Cardiology/European Respiratory Society derived three- and four-strata risk stratification models in pulmonary arterial hypertension: introducing an internet-based risk stratification calculator.
    Ahmed A; Ahmed S; Kempe D; Rådegran G
    Eur Heart J Open; 2023 Mar; 3(2):oead012. PubMed ID: 36959867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis.
    Rosenkranz S; Pausch C; Coghlan JG; Huscher D; Pittrow D; Grünig E; Staehler G; Vizza CD; Gall H; Distler O; Delcroix M; Ghofrani HA; Ewert R; Kabitz HJ; Skowasch D; Behr J; Milger K; Halank M; Wilkens H; Seyfarth HJ; Held M; Scelsi L; Neurohr C; Vonk-Noordegraaf A; Ulrich S; Klose H; Claussen M; Eisenmann S; Schmidt KH; Remppis BA; Skride A; Jureviciene E; Gumbiene L; Miliauskas S; Löffler-Ragg J; Lange TJ; Olsson KM; Hoeper MM; Opitz C
    J Heart Lung Transplant; 2023 Jan; 42(1):102-114. PubMed ID: 36333206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary Artery Strain Predicts Prognosis in Pulmonary Arterial Hypertension.
    Zhong L; Leng S; Alabed S; Chai P; Teo L; Ruan W; Low TT; Wild JM; Allen JC; Lim ST; Tan JL; Yip JW; Swift AJ; Kiely DG; Tan RS
    JACC Cardiovasc Imaging; 2023 Aug; 16(8):1022-1034. PubMed ID: 37052561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis.
    Hoeper MM; Dwivedi K; Pausch C; Lewis RA; Olsson KM; Huscher D; Pittrow D; Grünig E; Staehler G; Vizza CD; Gall H; Distler O; Opitz C; Gibbs JSR; Delcroix M; Park DH; Ghofrani HA; Ewert R; Kaemmerer H; Kabitz HJ; Skowasch D; Behr J; Milger K; Lange TJ; Wilkens H; Seyfarth HJ; Held M; Dumitrescu D; Tsangaris I; Vonk-Noordegraaf A; Ulrich S; Klose H; Claussen M; Eisenmann S; Schmidt KH; Swift AJ; Thompson AAR; Elliot CA; Rosenkranz S; Condliffe R; Kiely DG; Halank M
    Lancet Respir Med; 2022 Oct; 10(10):937-948. PubMed ID: 35777416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of two predictive models for survival in pulmonary arterial hypertension.
    Sitbon O; Benza RL; Badesch DB; Barst RJ; Elliott CG; Gressin V; Lemarié JC; Miller DP; Muros-Le Rouzic E; Simonneau G; Frost AE; Farber HW; Humbert M; McGoon MD
    Eur Respir J; 2015 Jul; 46(1):152-64. PubMed ID: 25837032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison Between REVEAL Lite 2 and COMPERA 2.0 for Risk Stratification in Pulmonary Arterial Hypertension.
    Sahay S; Villasmil Hernandez N; Wang F; Wooten M; Nguyen DT; Fauvel C; Benza R; Graviss EA
    Chest; 2024 Mar; ():. PubMed ID: 38447640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies.
    Benza RL; Gomberg-Maitland M; Elliott CG; Farber HW; Foreman AJ; Frost AE; McGoon MD; Pasta DJ; Selej M; Burger CD; Frantz RP
    Chest; 2019 Aug; 156(2):323-337. PubMed ID: 30772387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interest of TAPSE/sPAP ratio for noninvasive pulmonary arterial hypertension risk assessment.
    Fauvel C; Raitiere O; Boucly A; De Groote P; Renard S; Bertona J; Lamblin N; Artaud-Macari E; Viacroze C; Schleifer D; Dominique S; Pichon J; Jais X; Montani D; Sitbon O; Savale L; Humbert M; Bauer F
    J Heart Lung Transplant; 2022 Dec; 41(12):1761-1772. PubMed ID: 36202691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension.
    Hoeper MM; Pausch C; Olsson KM; Huscher D; Pittrow D; Grünig E; Staehler G; Vizza CD; Gall H; Distler O; Opitz C; Gibbs JSR; Delcroix M; Ghofrani HA; Park DH; Ewert R; Kaemmerer H; Kabitz HJ; Skowasch D; Behr J; Milger K; Halank M; Wilkens H; Seyfarth HJ; Held M; Dumitrescu D; Tsangaris I; Vonk-Noordegraaf A; Ulrich S; Klose H; Claussen M; Lange TJ; Rosenkranz S
    Eur Respir J; 2022 Jul; 60(1):. PubMed ID: 34737226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Left Heart Disease Risk Factors on Outcomes in Pulmonary Arterial Hypertension Therapy.
    Kearney K; Brown K; Celermajer DS; Collins N; Cordina R; Corrigan C; Dwyer N; Feenstra J; Keating D; Keogh A; Kotlyar E; Lavender M; McWilliams T; Williams T; Whitford H; Weintraub R; Wrobel J; Ellender C; Anderson J; Lau EM;
    Chest; 2024 Apr; 165(4):967-977. PubMed ID: 37951349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry.
    Boucly A; Weatherald J; Savale L; de Groote P; Cottin V; Prévot G; Chaouat A; Picard F; Horeau-Langlard D; Bourdin A; Jutant EM; Beurnier A; Jevnikar M; Jaïs X; Simonneau G; Montani D; Sitbon O; Humbert M
    Eur Respir J; 2022 Jun; 59(6):. PubMed ID: 34737227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantation.
    Vicaire H; Pavec JL; Mercier O; Montani D; Boucly A; Roche A; Pradère P; Dauriat G; Feuillet S; Pichon J; Jevnikar M; Beurnier A; Jaïs X; Fadel E; Sitbon O; Humbert M; Savale L
    J Heart Lung Transplant; 2022 Sep; 41(9):1285-1293. PubMed ID: 35778258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk stratification in pulmonary arterial hypertension using Bayesian analysis.
    Kanwar MK; Gomberg-Maitland M; Hoeper M; Pausch C; Pittrow D; Strange G; Anderson JJ; Zhao C; Scott JV; Druzdzel MJ; Kraisangka J; Lohmueller L; Antaki J; Benza RL
    Eur Respir J; 2020 Aug; 56(2):. PubMed ID: 32366491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal trends in pulmonary arterial hypertension: results from the COMPERA registry.
    Hoeper MM; Pausch C; Grünig E; Staehler G; Huscher D; Pittrow D; Olsson KM; Vizza CD; Gall H; Distler O; Opitz C; Gibbs JSR; Delcroix M; Ghofrani HA; Rosenkranz S; Park DH; Ewert R; Kaemmerer H; Lange TJ; Kabitz HJ; Skowasch D; Skride A; Claussen M; Behr J; Milger K; Halank M; Wilkens H; Seyfarth HJ; Held M; Dumitrescu D; Tsangaris I; Vonk-Noordegraaf A; Ulrich S; Klose H
    Eur Respir J; 2022 Jun; 59(6):. PubMed ID: 34675047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivation of a Risk Score (REVEAL-ECHO) Based on Echocardiographic Parameters of Patients With Pulmonary Arterial Hypertension.
    El-Kersh K; Zhao C; Elliott G; Farber HW; Gomberg-Maitland M; Selej M; Garcia-Ferrer J; Benza R
    Chest; 2023 May; 163(5):1232-1244. PubMed ID: 36634897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of children with newly diagnosed pulmonary arterial hypertension: results from the global TOPP registry.
    Ploegstra MJ; Ivy DD; Beghetti M; Bonnet D; Alehan D; Ablonczy L; Mattos S; Bowers D; Humpl T; Berger RMF;
    Eur Heart J Qual Care Clin Outcomes; 2024 Jan; 10(1):66-76. PubMed ID: 36972621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.